CC
AMPH icon

Centiva Capital’s Amphastar Pharmaceuticals AMPH Stock Holding History

Centiva Capital’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-24,161
Closed -$555K – 1083
2025
Q2 		$555K Buy
+24,161
New +$600K 0.04% 910
2025
Q1 		– Sell
-9,803
Closed -$364K – 1525
2024
Q4 		$364K Buy
9,803
+3,338
+52% +$153K 0.01% 1022
2024
Q3 		$314K Sell
6,465
-17,110
-73% -$751K 0.01% 1544
2024
Q2 		$943K Buy
+23,575
New +$977K 0.05% 812
2023
Q3 		– Sell
-11,189
Closed -$643K – 1698
2023
Q2 		$643K Buy
11,189
+5,845
+109% +$259K 0.03% 713
2023
Q1 		$200K Buy
+5,344
New +$175K 0.01% 1240

Other funds holding AMPH

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return